-
1دورية أكاديمية
المؤلفون: Jiang, ZefeiAff1, IDs4159102302677x_cor1, Ouyang, Quchang, Sun, Tao, Zhang, Qingyuan, Teng, Yuee, Cui, Jiuwei, Wang, Haibo, Yin, Yongmei, Wang, Xiaojia, Zhou, Xin, Wang, Yongsheng, Sun, Gang, Wang, Jingfen, Zhang, Lili, Yang, Jin, Qian, Jun, Yan, Min, Liu, Xinlan, Yi, Tienan, Cheng, Ying, Li, Man, Zang, Aimin, Wang, Shusen, Wang, Chuan, Wu, Xinhong, Cheng, Jing, Li, Hui, Lin, Ying, Geng, Cuizhi, Gu, Kangsheng, Xie, Chunwei, Xiong, Huihua, Wu, Xiaohong, Yang, Junlan, Li, Qingshan, Chen, Yiding, Li, Fanfan, Zhang, Anqin, Zhang, Yongqiang, Wu, Yudong, Nie, Jianyun, Liu, Qiang, Wang, Kun, Mo, Xueli, Chen, Lilin, Pan, Yueyin, Fu, Peifen, Zhang, Helong, Pang, Danmei, Sheng, Yuan, Han, Yunwei, Wang, HongxiaAff52, Aff53, Cang, Shundong, Luo, Xianming, Yu, Wenbo, Deng, Rong, Yang, Chaoqiang, Keegan, Patricia
المصدر: Nature Medicine. 30(1):249-256
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Zhang, Peng, Mo, Xueli, Du, Jun, Fan, Changsheng
المصدر: In Asian Journal of Surgery September 2020 43(9):944-945
-
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية
المؤلفون: Qian, Shenxian, Somlo, George, Zhou, Bingsen, Zhu, Lijun, Mi, Shu, Mo, Xueli, Cheung, Eric M., Qiu, Weihua, Lin, Ren-Jang, Rossi, John, Holtz, Melissa, Chu, Peiguo, Yen, Yun
المصدر: Oligonucleotides; Spring 2005, Vol. 15 Issue: 1 p1-11, 11p
-
7دورية أكاديمية
المؤلفون: Zhou B; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California 91010, USA., Liu X, Mo X, Xue L, Darwish D, Qiu W, Shih J, Hwu EB, Luh F, Yen Y
المصدر: Cancer research [Cancer Res] 2003 Oct 15; Vol. 63 (20), pp. 6583-94.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Cell Cycle Proteins* , DNA Repair*, Ribonucleoside Diphosphate Reductase/*physiology , Ribonucleotide Reductases/*physiology , Tumor Suppressor Protein p53/*genetics, Cell Line, Tumor ; DNA Damage ; Gene Expression Regulation, Neoplastic/physiology ; Gene Expression Regulation, Neoplastic/radiation effects ; Humans ; Hydroxyurea/pharmacology ; KB Cells ; Male ; Mutation ; Prostatic Neoplasms/enzymology ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Protein Binding/radiation effects ; RNA, Antisense/genetics ; RNA, Messenger/biosynthesis ; RNA, Messenger/genetics ; Ribonucleoside Diphosphate Reductase/biosynthesis ; Ribonucleoside Diphosphate Reductase/genetics ; Ribonucleoside Diphosphate Reductase/metabolism ; Ribonucleotide Reductases/biosynthesis ; Ribonucleotide Reductases/genetics ; Ribonucleotide Reductases/metabolism ; Transfection ; Tumor Suppressor Proteins/metabolism ; Ultraviolet Rays
-
8دورية أكاديمية
المؤلفون: Zhou B; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA., Mi S, Mo X, Shih J, Tsai J, Hu E, Hsu M, Kay K, Yen Y
المصدر: Anticancer research [Anticancer Res] 2002 May-Jun; Vol. 22 (3), pp. 1369-77.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Print ISSN: 0250-7005 (Print) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Deoxycytidine/*administration & dosage , Deoxycytidine/*analogs & derivatives , Hydroxyurea/*administration & dosage, Blotting, Northern ; Blotting, Western ; Cell Cycle/drug effects ; Cytidine Diphosphate/metabolism ; DNA, Neoplasm/metabolism ; Deoxyribonucleotides/metabolism ; Drug Administration Schedule ; Drug Synergism ; Humans ; KB Cells ; Ribonucleoside Diphosphate Reductase/antagonists & inhibitors ; Ribonucleoside Diphosphate Reductase/biosynthesis ; Ribonucleoside Diphosphate Reductase/genetics ; Ribonucleoside Diphosphate Reductase/metabolism ; Gemcitabine